358
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer

, , , , , , & ORCID Icon show all
Pages 55-65 | Received 08 Oct 2022, Accepted 29 Dec 2022, Published online: 14 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)